However, as the definition of IC/BPS appears to be expanding from a bladder disease to a chronic pain syndrome, reliable new outcome measures will have to be developed
TNF- Inhibitor Therapy and Its Clinical Impact With infliximab as the first biologic agent approved for the therapy of CD in 1998, TNF- inhibitors have a long history regarding the treatment of chronic inflammatory diseases
These coordinated molecular effects result in organized tissue repair rather than dysregulated scarring
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology
In one analysis, GHK-Cu was found to influence the expression of over 4,000 human genes, including those involved in inflammation resolution, DNA repair, antioxidant response, and ubiquitin-proteasome system regulation